Q: What is Imatinib?

Imatinib belongs to a class of medications known as tyrosine kinase inhibitors . It works by blocking the action of specific abnormal proteins that signal cancer cells to multiply, which helps stop or slow the spread of the disease. This targeted approach focuses on the underlying molecular mechanisms that allow certain types of cancer to grow and survive in the body.

Q: What is Imatinib used for?

Imatinib is used to treat: Chronic myeloid leukemia Acute lymphoblastic leukemia Gastrointestinal stromal tumor and others.

Q: How does Imatinib work?

Targeting Cancer Proteins Imatinib belongs to a class of medications known as kinase inhibitors. It is designed to target and block the activity of specific proteins called tyrosine kinases. In certain types of cancer, these proteins are overactive or abnormal, acting like a switch that is stuck in the "on" position, which tells cells to multiply uncontrollably. How It Stops Cell Growth The medication works by binding to these abnormal proteins, such as the Bcr-Abl protein found in some types of leukemia. When imatinib attaches to the protein, it prevents the protein from sending growth signals to the cancer cells. This process can lead to several outcomes: Slowing progression: It reduces the speed at which cancer cells reproduce. Inducing cell death: Without the necessary growth signals, some cancer cells may stop functioning and die. Protecting healthy cells: Because it is a targeted therapy, it is designed to focus primarily on cells with the abnormal protein, though it can still affect some healthy cells. By interfering with these specific biological pathways, imatinib helps manage the underlying cause of cell overgrowth in conditions like chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST).

Q: What are the brand names for Imatinib?

Imatinib is sold under the brand names Gleevec and Glivec .

Q: What are the active ingredients in Imatinib?

The active ingredient in Imatinib is imatinib .

Q: What are the side effects of Imatinib?

Common side effects of Imatinib may include: Nausea Diarrhea Muscle cramps and others. Always consult with a healthcare professional about potential side effects.

Q: What drug class is Imatinib?

Imatinib belongs to the tyrosine kinase inhibitor drug class.

Q: What is the dosage of Imatinib and how do I take it?

How to Take Imatinib Imatinib is taken by mouth, usually once or twice a day. It should be taken with a meal and a large glass of water to help reduce the risk of stomach irritation. It is important to take this medication regularly at the same time each day to maintain a consistent level in your system. Administration Tips Swallow the tablets whole whenever possible. If you have difficulty swallowing the tablets, they may be dissolved in a glass of water or apple juice. Stir the mixture until the tablet has completely broken down and drink the entire contents immediately. Wash your hands after handling the tablets, especially if they are broken or dissolved. Missed Dose If you miss a dose, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and continue with your regular routine. Do not take two doses at the same time to make up for a missed dose.

Q: Is Imatinib safe during pregnancy and breastfeeding?

Pregnancy Imatinib may cause harm to an unborn baby if taken during pregnancy. Healthcare providers typically recommend that individuals who can become pregnant have a pregnancy test before starting this medication to ensure they are not pregnant. It is important to notify a doctor immediately if pregnancy occurs while using this drug. Effective birth control should be used throughout the duration of treatment and for at least 14 days after the final dose is taken. Discussing reproductive plans and the most reliable forms of contraception with a healthcare provider is recommended for those of childbearing potential. Breastfeeding It is not recommended to breastfeed while taking imatinib because the medication may pass into breast milk and could cause serious side effects in a nursing infant. Most clinical guidelines advise waiting at least one month after the final dose of imatinib before resuming breastfeeding. Patients should consult with their healthcare team to determine the safest feeding options for their situation.

Question 1

What is Imatinib?

Accepted Answer

Imatinib belongs to a class of medications known as tyrosine kinase inhibitors. It works by blocking the action of specific abnormal proteins that signal cancer cells to multiply, which helps stop or slow the spread of the disease.

This targeted approach focuses on the underlying molecular mechanisms that allow certain types of cancer to grow and survive in the body.

Question 2

What is Imatinib used for?

Accepted Answer

Imatinib is used to treat:

Chronic myeloid leukemia
Acute lymphoblastic leukemia
Gastrointestinal stromal tumor
and others.

Question 3

How does Imatinib work?

Accepted Answer

Targeting Cancer Proteins

Imatinib belongs to a class of medications known as kinase inhibitors. It is designed to target and block the activity of specific proteins called tyrosine kinases. In certain types of cancer, these proteins are overactive or abnormal, acting like a switch that is stuck in the "on" position, which tells cells to multiply uncontrollably.

How It Stops Cell Growth

The medication works by binding to these abnormal proteins, such as the Bcr-Abl protein found in some types of leukemia. When imatinib attaches to the protein, it prevents the protein from sending growth signals to the cancer cells. This process can lead to several outcomes:

Slowing progression: It reduces the speed at which cancer cells reproduce.
Inducing cell death: Without the necessary growth signals, some cancer cells may stop functioning and die.
Protecting healthy cells: Because it is a targeted therapy, it is designed to focus primarily on cells with the abnormal protein, though it can still affect some healthy cells.

By interfering with these specific biological pathways, imatinib helps manage the underlying cause of cell overgrowth in conditions like chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST).

Question 4

What are the brand names for Imatinib?

Accepted Answer

Imatinib is sold under the brand names Gleevec and Glivec.

Question 5

What are the active ingredients in Imatinib?

Accepted Answer

The active ingredient in Imatinib is imatinib.

Question 6

What are the side effects of Imatinib?

Accepted Answer

Common side effects of Imatinib may include:

Nausea
Diarrhea
Muscle cramps
and others.

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Imatinib?

Accepted Answer

Imatinib belongs to the tyrosine kinase inhibitor drug class.

Question 8

What is the dosage of Imatinib and how do I take it?

Accepted Answer

How to Take Imatinib

Imatinib is taken by mouth, usually once or twice a day. It should be taken with a meal and a large glass of water to help reduce the risk of stomach irritation. It is important to take this medication regularly at the same time each day to maintain a consistent level in your system.

Administration Tips

Swallow the tablets whole whenever possible.
If you have difficulty swallowing the tablets, they may be dissolved in a glass of water or apple juice. Stir the mixture until the tablet has completely broken down and drink the entire contents immediately.
Wash your hands after handling the tablets, especially if they are broken or dissolved.

Missed Dose

If you miss a dose, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and continue with your regular routine. Do not take two doses at the same time to make up for a missed dose.

Question 9

Is Imatinib safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Imatinib may cause harm to an unborn baby if taken during pregnancy. Healthcare providers typically recommend that individuals who can become pregnant have a pregnancy test before starting this medication to ensure they are not pregnant. It is important to notify a doctor immediately if pregnancy occurs while using this drug.

Effective birth control should be used throughout the duration of treatment and for at least 14 days after the final dose is taken. Discussing reproductive plans and the most reliable forms of contraception with a healthcare provider is recommended for those of childbearing potential.

Breastfeeding

It is not recommended to breastfeed while taking imatinib because the medication may pass into breast milk and could cause serious side effects in a nursing infant. Most clinical guidelines advise waiting at least one month after the final dose of imatinib before resuming breastfeeding. Patients should consult with their healthcare team to determine the safest feeding options for their situation.

Question 10

What forms and strengths does Imatinib come in?

Accepted Answer

Imatinib is currently available in the following dosage form:

Oral Tablet: This medication is taken by mouth, typically once or twice daily as directed by a healthcare provider.

For individuals who have difficulty swallowing tablets, the medication can often be dissolved in a glass of water or apple juice. It is generally recommended to take this medication with a meal and a large glass of water to help prevent irritation of the digestive tract.

Question 11

What is the FDA approval status of Imatinib?

Accepted Answer

FDA Approval and Indications

Imatinib was first approved by the U.S. Food and Drug Administration (FDA) in 2001. It is a kinase inhibitor approved for the treatment of various conditions, including:

Chronic Myeloid Leukemia (CML): For patients in various stages of the disease, including newly diagnosed cases.
Acute Lymphoblastic Leukemia (ALL): Specifically for Philadelphia chromosome-positive cases in both adults and children.
Myelodysplastic or Myeloproliferative Diseases (MDS/MPD): Associated with specific gene re-arrangements.
Systemic Mastocytosis: For certain aggressive forms of the condition without specific mutations.
Hypereosinophilic Syndrome (HES) and Chronic Eosinophilic Leukemia (CEL): For adult patients.
Gastrointestinal Stromal Tumors (GIST): For treatment after surgery or for tumors that cannot be removed or have spread.
Dermatofibrosarcoma Protuberans (DFSP): For tumors that are recurrent, cannot be removed by surgery, or have spread to other parts of the body.

Regulatory Status

Imatinib is available only with a doctor's prescription. While it is a potent medication with significant side effects that require close medical monitoring, it does not currently carry a boxed warning or require a Risk Evaluation and Mitigation Strategy (REMS) program according to the provided sources. It is available in both brand-name and generic versions.

Question 12

What should I know about Imatinib and cost?

Accepted Answer

Generic vs.

Brand Name

Imatinib is available as a generic medication and under the brand name Gleevec. Generic versions are generally significantly less expensive than the brand-name drug. Both versions contain the same active ingredient and are held to the same standards for safety and effectiveness.

Insurance Coverage

Most insurance plans, including Medicare and private insurance, provide coverage for imatinib. However, because it is often classified as a specialty medication, it may be placed on a higher cost-sharing tier. This means you might be responsible for a significant co-payment or coinsurance amount. Some insurance companies may also require prior authorization before they will cover the cost of the drug.

Factors Affecting Price

The total price of imatinib can vary based on several factors:

Dosage: The strength of the tablets (100 mg or 400 mg) and the total daily dose prescribed.
Pharmacy: Prices can differ between retail pharmacies, mail-order services, and specialty pharmacies.
Location: Geographic location and local pharmacy competition can influence the retail price.

Financial Assistance Programs

If you have difficulty paying for imatinib, there are resources that may help reduce the cost:

Patient Assistance Programs: Some pharmaceutical manufacturers offer programs to provide medications at a lower cost or for free to patients who meet specific income and insurance requirements.
Co-pay Cards: For patients with commercial insurance, manufacturers may offer co-pay savings cards to help lower out-of-pocket expenses for brand-name drugs.
Non-profit Organizations: Certain foundations offer grants to help patients cover the costs of cancer treatments and related expenses.

It is recommended to discuss financial concerns with your healthcare provider or a social worker, as they can often help navigate these assistance options.

Imatinib

📋Overview

How It Works

Uses

Brand Names

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Imatinib

Hospitals.net Disclosure